Temporary Disabled. :) please Go back Hepatitis A, B & C www.fgks.org » Address: [go: up one dir, main page] Include Form Remove Scripts Accept Cookies Show Images Show Referer Rotate13 Base64 Strip Meta Strip Title Session Cookies International HIV & AIDS charity DonateFundraising About Us Our Partners Help & Advice Contact Us Facebook Linked in Twitter Newsletter Copyright © AVERT skip to menu Hepatitis A, B & C back to top What is Hepatitis? 'Hepatitis' refers to viral infections that cause inflammation of the liver. Hepatitis A, B and C are the most common types. Each have different causes and symptoms. Hepatitis A Hepatitis B Hepatitis C back to top Hepatitis A Hepatitis A is the most common of the seven known types of viral hepatitis. Infection with the hepatitis A virus leads to inflammation of the liver, but complications are rarely serious. How hepatitis A is spread The hepatitis A virus (HAV) is found in the faeces of someone infected with the virus. It only takes a tiny amount of faeces getting inside another person’s mouth to cause hepatitis A infection. Personal hygiene, such as careful hand washing, can minimise the risk of the virus being passed on. HAV is a common infection in many parts of the world where sanitation and sewage infrastructure is poor. Often people become infected with HAV by eating or drinking contaminated food or water. Hepatitis A is also classed as a sexually transmitted disease (STD) because it can be passed on sexually, particularly during activities such as anilingus (rimming). The washing of genital and anal areas before sex, and the use of condoms or dental dams can help to prevent this risk. Hepatitis A can affect all age groups. Once a person is exposed to the virus it takes between 2 and 6 weeks to produce symptoms. Signs and symptoms of hepatitis A It is possible to experience mild or no symptoms whatsoever, but even if this is the case the person’s faeces will still be infectious to others. Many people who become infected with HAV will have symptoms that include: A short, mild, flu-like illness; nausea, vomiting and diarrhoea; loss of appetite; weight loss; jaundice (yellow skin and whites of eyes, darker yellow urine and pale faeces); itchy skin; abdominal pain. The infection usually clears in up to 2 months, but may occasionally recur or persist longer in some people. Once a person has been infected and their body has fought off the virus they are permanently immune. Occasionally symptoms may be severe and require monitoring in hospital. There are rarely any complications with hepatitis A infection. Permanent damage to the liver is very unlikely, but in extremely rare cases the infection can be fatal, particularly in older people. Where to go for help If you have any symptoms or you are worried you may have been infected with hepatitis A, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can. Some countries have specific sexual health clinics that can help you directly. What does a positive test result mean? HAV is tested for using a blood test. A positive test result means the patient has either had a past infection or is currently infected. The type of antibody detected in the test will indicate whether the infection is current or has been cleared. A patient who tests positive may be asked about recent contacts and sexual partners that may need to be tested too. A patient who has already had the infection and fought it off is naturally immune to HAV. What does a negative test result mean? A negative test result means the patient is not infected with Hepatitis A. If the patient is believed to be at high or ongoing risk of infection, a doctor may advise immunisation. Treatment for hepatitis A There is no specific treatment for HAV and most people fight off the virus naturally, returning to full health within a couple of months. The doctor will advise avoiding alcohol and fatty foods as these can be hard for the liver to process and may exacerbate the inflammation. Patients should get plenty of rest and eat a nutritious diet. They should also ensure they do not spread HAV by washing their hands after using the toilet and before preparing food. Patients with more severe symptoms may be monitored in hospital for a short period. Hepatitis A immunisation Hepatitis A immunisation is given in a series of injections. The first single injection in the arm gives protection for a year. The second booster injection at 6 to 12 months extends protection for up to 10 years. The hepatitis A vaccine may be routinely recommended for young children living in areas with high incidence of hepatitis A, and anyone travelling to countries where hepatitis A is endemic. In addition, immunisation may be recommended for people whose sexual practices are likely to put them at risk. Immunisation may also be recommended to prevent hepatitis A developing if a person suspects they have been exposed to the virus. Follow-up Someone who is infected with hepatitis A should limit the amount of alcohol they drink. Their doctor may also offer dietary advice. The doctor will advise about any precautions necessary to avoid infecting others with the virus. back to top back to top Hepatitis B Hepatitis B is similar to hepatitis A in its symptoms, but is more likely to cause chronic long-term illness and permanent damage to the liver if not treated. How hepatitis B is spread The hepatitis B virus (HBV) is very common worldwide, with more than 350 million people infected. Those with long term HBV are at high risk of developing liver cirrhosis or liver cancer. Hepatitis B is most frequently passed on through the exchange of bodily fluids with an infected person. HBV is estimated to be 50 to 100 times more infectious than HIV.1 HBV can be spread in the following ways: By unprotected (without a condom) penetrative sex (when the penis enters the anus, vagina or mouth) with someone who is infectious. Also by sex that draws blood with someone who is infected. By sharing contaminated needles or other drug-injecting equipment. By using non-sterilised equipment for tattooing, acupuncture or body piercing. From an infected mother to her baby, most commonly during delivery. Immunisation of the baby at birth prevents the transmission of hepatitis B. Through a blood transfusion in a country where blood is not screened for blood-borne viruses such as HBV. Hepatitis B cannot be spread through sneezing, coughing, hugging or coming in contact with the faeces of someone who is infected. Signs and symptoms of hepatitis B Many people who become infected with HBV experience mild symptoms or no symptoms at all, but they may still carry the infectious virus and pass it on to others. When symptoms do appear they are similar to those of hepatitis A and may include: A short, mild, flu-like illness; nausea, vomiting and diarrhoea; loss of appetite; weight loss; jaundice (yellow skin and whites of eyes, darker yellow urine and pale faeces); itchy skin. If symptoms become severe then a person with hepatitis B may be admitted to hospital. Most adults infected with the hepatitis B virus fully recover and develop life-long immunity. Between 2% and 10% of individuals infected as adults will become chronic carriers, which means they will be infectious to others and can develop chronic liver damage. Infected children, especially newborn babies, are much more likely to become chronic carriers. If a person lives with hepatitis B infection for a number of years then they may develop the following complications: chronic hepatitis liver cirrhosis liver cancer Where to go for help If you have any symptoms or you are worried you may have been infected with hepatitis B, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can. Some countries have specific sexual health clinics that can help you directly. What does a positive test result mean? A positive test result could indicate either of the following: A past infection. This means the patient has already been in contact with hepatitis B and their immune system has succeeded in fighting off the virus. The patient will then have a natural immunity to the virus. The patient is a carrier. This means the patient is carrying HBV and can pass it on to others. The person may not display any symptoms but could be at risk of developing chronic liver disease. A doctor may perform a number of different types of test to distinguish between current and past infections, and to estimate how infectious a patient with a current infection may be. What does a negative test result mean? This result generally means the patient has never been infected with HBV and therefore has no natural immunity against the virus. If the person suspects they may have been recently exposed to HBV, the doctor may advise them to take a repeat test to confirm their negative status, and may also advise immunisation against hepatitis B. Treatment for hepatitis B In most countries a patient with a positive test result will be referred to a specialist who will carry out further tests to determine the degree to which hepatitis B may be affecting the liver, and what may be the best treatment options. In these tests a small sample of liver tissue may need to be taken (a liver biopsy). In the majority of patients with active HBV, symptoms will not be severe and treatment will not be required. The patient will be monitored and after a few months the patient’s immune system should fight off the virus, giving the patient natural immunity. In around 5% of adults, 30-50% of young children (aged 1-4), and 90% of infants, HBV infection will become chronic. The virus is more deadly to the young and those that are infected at birth have a 25% chance of developing a life-threatening liver-related illness. Antiviral medication is given as treatment to those with chronic symptoms to help prevent further liver damage. These medications may be injected or given in pill form. Examples are Interferon Alpha, Lamivudine and Baraclude. Treatment usually lasts 6 months, during which time the patient will be carefully monitored. Regardless of whether the infection is producing symptoms or not, the patient will be advised to avoid alcohol, get plenty of rest and maintain a healthy diet. Hepatitis B immunisation Three immunisation injections are given over a period of 3-6 months. A blood test is taken once the course of injections is completed to check they have worked. Immunity should last for at least 5 years. Follow-up A patient with an active infection will be advised to have regular blood tests and physical check-ups to monitor the virus, even if they are not receiving treatment. All carriers of HBV should expect to be referred to specialist services. The doctor or nurse may advise the patient to avoid alcohol, fatty foods and follow a low-salt diet. They will also describe any precautions necessary to ensure the patient avoids infecting others with the virus, such as not sharing toothbrushes or shaving equipment. It is important to use a condom for penetrative sex to prevent passing on the virus. Sexual partners of the patient should be tested and immunised against HBV (if not already infected). back to top back to top Hepatitis C Hepatitis C, like other forms of hepatitis, causes inflammation of the liver. The hepatitis C virus is transferred primarily through blood, and is more persistent than hepatitis A or B.2 How hepatitis C is spread The hepatitis C virus (HCV) can be spread in the following ways: By sharing drug-injecting equipment (needles, heating spoons, etc). This is the primary transmission route for HCV outside sub-Saharan Africa. By using non-sterilised equipment for tattooing, acupuncture or body piercing. This can be a problem in countries where tattooing or scarification is a traditional ritual practice. Through exposure to blood during unprotected sex with an infected person. Blood may be present because of genital sores, cuts or menstruation. Sexual transmission is an uncommon way of becoming infected with hepatitis C. Rarely, from an infected mother to her baby during childbirth. The risk may be greater if the mother is also infected with HIV. Through blood transfusion. In many developing countries blood is not screened (tested) for the hepatitis C virus. All blood for transfusion in the UK and USA is tested. By sharing equipment used to snort cocaine. Usually this is a rolled banknote, which can become contaminated with blood from a person’s nose. Hepatitis C cannot be passed on by hugging, sneezing, coughing, sharing food or water, sharing cutlery, or casual contact. Signs and symptoms of hepatitis C Many people do not have symptoms when they become infected with hepatitis C. Symptoms may emerge later, taking anywhere between 15 and 150 days to develop. Occasionally a person will not develop any symptoms and their immune system will successfully clear the virus without their knowledge. An infected person without symptoms can still act as a carrier and pass the virus on to others. Symptoms may include: A short, mild, flu-like illness; nausea and vomiting; diarrhoea; loss of appetite; weight loss; jaundice (yellow skin and whites of eyes, darker yellow urine and pale faeces); itchy skin. About 20% of individuals who become infected with HCV will clear the virus from their body within 6 months, though this does not mean they are immune from future infection with HCV. The other 80% of people will develop chronic hepatitis C infection, during which the virus may cause mild symptoms or no symptoms at all. These people will however carry the hepatitis C virus for the rest of their lives and will remain infectious to others. If a person lives with hepatitis C infection for a number of years then they may develop the following complications: chronic hepatitis liver cirrhosis liver cancer If symptoms become severe then a person with hepatitis C may be admitted to hospital for monitoring and treatment. Where to go for help If you have any symptoms or you are worried you may have been infected with hepatitis C, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can. Some countries have specific sexual health clinics that can help you directly. The tests for hepatitis C Tests for the hepatitis C virus have only been available since 1989. A doctor can diagnose hepatitis C by carrying out blood tests that detect HCV antibodies in the blood. What does a positive test result mean? The first test searches for HCV antibodies in the patient’s blood. A positive result shows that the person has been exposed to the hepatitis C virus and their immune system has responded by producing antibodies. This may mean that the patient is a carrier of the hepatitis C virus. Alternatively, the patient may have recently cleared an HCV infection and still have antibodies in their blood. Further tests will be conducted to find out whether the patient has a current infection. A specialist will carry out a blood test that looks for the genetic material of the hepatitis C virus itself instead of the antibodies. This test will identify whether the virus is still present. If the patient has successfully cleared the virus, this does not mean they are immune to reinfection. What does a negative test result mean? A negative result generally means the patient has never been infected with HCV. However, as the tests rely on the detection of antibodies to HCV, and the antibodies can take some months to develop, the doctor may advise the patient to take a repeat test if they believe they may have been recently exposed to the virus. Treatment for hepatitis C To determine the extent to which the liver has been affected by hepatitis C, other tests may be carried out. These include liver function tests, which measure substances (specific proteins and enzymes) in the patient’s blood, showing how effectively the liver is working. A liver biopsy may also be carried out. A fine hollow needle is passed through the skin into the liver and a small sample is taken. The sample is then examined under a microscope to gauge the amount of liver damage (inflammation, scarring and cirrhosis). Treatment combines the antiviral drugs interferon and ribavirin. Although treatment has improved in recent years, the success rates vary depending on which genotype the patient has and how long they have had hepatitis C. In 2011, the FDA approved a new drug called Victrelis (for the treatment of the genotype 1 strain of hepatitis C). When taken alongside existing drugs, Victrelis cured more than 60 percent of patients in clinical trials compared to between 20-40 percent of patients when existing drugs were taken alone.3 Unlike other drugs for hepatitis C, Victrelis is a protease inhibitor, similar to those used to treat HIV. Adherence to this drug is essential to prevent drug resistance. The antiviral drugs may cause significant side effects that may be intolerable for some people. These include: headaches flu-like symptoms nausea tiredness body aches depression skin rashes A patient will also require regular check-ups to monitor their progress. It is important to remember that if HCV treatment is effective and the infection is cleared, this does not mean the patient has future immunity to hepatitis C. Follow-up If a patient has been diagnosed with hepatitis C infection, they will be advised to have regular blood tests and physical check-ups. The infected person should limit the amount of alcohol they drink as alcohol puts strain on the liver. The doctor may also advise avoiding fatty foods and following a low-salt diet. Prevention Currently, there is no vaccine for hepatitis C, but research is in progress. Like HIV, HCV can mutate easily, which makes vaccine development complicated. As no vaccine exists, all measures should be taken to prevent HCV transmission. Injecting drug users should never share any needles, syringes or mixing spoons, as blood can be transferred between users. Infection through penetrative sex does occur, although it is not common. If a person is infected with HCV, it is advisable for them to use a condom for penetrative sex to ensure they do not pass on the virus to their partners through any open genital cuts or sores. People should avoid sharing toothbrushes, shaving equipment (especially razors), or anything else that may be contaminated with infected blood. The doctor will advise the patient of any precautions necessary to avoid infecting others with the virus. back to top email print tweet more Where Next? AVERT.org has more about: Sexually transmitted diseases Syphilis Genital warts HIV symptoms Back to top Sign up to our Newsletter Donate References back to top WHO (October 2000), Hepatitis B - Fact sheet No 204 Rockstroh, J K (2011) 'The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel' AIDS 25 Pollack, A (2011, 13th May) 'Merck's Hepatitis C Drug Wins F.D.A Approval' The New York Times english español back to content home pageHIV & AIDS Topics EpidemicGlobal EpidemicAIDS & HIV Around the WorldAIDS : What is AIDS? What causes AIDS?HIV & AIDS NewsHIV : The virus that causes AIDSReflections on the Epidemic World AIDS DayMoney for HIV/AIDSFunding for HIV and AIDS Money for HIV/AIDSPEPFARThe Global Fund How different people are affected by HIV and AIDS Men Who Have Sex with Men (MSM)Children orphaned by HIV and AIDSChildren, HIV and AIDSHIV/AIDS and Vulnerable Groups Prisons, Prisoners and HIV/AIDSTransgender People and HIV/AIDSWomen and HIV/AIDSIssuesHIV & Injecting Drug Users HIV & AIDS Stigma and DiscriminationHIV and AIDS IssuesHIV and Sex WorkHistoryHIV and AIDS HistoryAIDS TimelineHistory of AIDS Up to 1986History of AIDS: 1987-1992History of AIDS: 1993-1997History of AIDS: 1998-2002History of AIDS: 2003-2006History of AIDS: 2007 OnwardsAVERT History History of the HIV and AIDS Charity AVERT AVERT: Early 1990s to the start of the InternetAVERT: Overseas projects & developing AVERT.orgAVERT: Southern African projects and AVERT.orgAVERT: The First Five YearsLiving with HIVLiving with HIV and AIDSAm I going to die?Emotional Needs and SupportHIV and PregnancyLearning You Are HIV PositiveLiving with HIV StoriesWhat is living with HIV?PreventionOverview of HIV preventionHIV Prevention Around the WorldIntroduction to HIV PreventionPrevention of HIV transmission from mother to childHIV Transmission from Mother-to-childPreventing Mother-to-child Transmission (PMTCT) in PracticePreventing Mother-to-child Transmission of HIV WHO Guidelines for PMTCT & BreastfeedingPrevention of HIV transmission through bloodBlood Safety and HIVNeedle Exchange and Harm ReductionPrevention of HIV Transmission through BloodAIDS and sex educationAbstinence and Sex EducationHIV Prevention through Sex EducationHIV/AIDS Education and Young PeopleIntroduction to HIV and AIDS EducationLessons and Activity PlansSex Education That WorksPrevention of sexual transmission of HIVCircumcision & HIVCondoms: Effectiveness, History and AvailabilityHIV Prevention StrategiesPrevention of Sexual Transmission of HIVSex Workers and HIV PreventionThe Female CondomUsing Condoms, Condom Types and SizesHIV treatment as preventionHIV Treatment As PreventionHIV Treatment for PreventionPost-exposure Prophylaxis Pre-exposure ProphylaxisScienceHIV scienceA Cure for AIDSA World Free from HIVHIV and AIDS VaccineHIV Causes AIDSHIV Drugs, Vaccines and Animal TestingHIV Structure and Life CycleHIV Types, Subtypes Groups and StrainsMicrobicidesThe Origin of HIV and AIDS StatisticsWorldwide HIV & AIDS StatisticsUnderstanding HIV and AIDS StatisticsWorldwide HIV & AIDS StatisticsWorldwide HIV & AIDS Statistics CommentaryAmerican HIV & AIDS StatisticsUnited States of America HIV & AIDS Statistics Canadian HIV & AIDS StatisticsCanada AIDS Statistics by Year and AgeCanada HIV Statistics SummaryLatin American & Caribbean HIV & AIDS StatisticsCaribbean HIV & AIDS StatisticsLatin America HIV & AIDS StatisticsAfrican HIV & AIDS StatisticsSouth Africa HIV & AIDS StatisticsSub-Saharan Africa HIV & AIDS StatisticsAsian HIV & AIDS StatisticsIndia HIV & AIDS StatisticsSouth East Asia HIV & AIDS StatisticsAustralian HIV & AIDS StatisticsAustralia HIV & AIDS StatisticsEuropean HIV & AIDS StatisticsEuropean HIV and AIDS StatisticsUK HIV and AIDS Statistics Transmission & Testing HIV transmissionAIDS: Fear and AnxietyCan You Get HIV From. . . ?Criminal Transmission of HIVHIV & AIDS SymptomsHIV and BreastfeedingHIV Transmission Questions & AnswersHIV testingHIV TestingHIV Testing Frequently Asked QuestionsTreatment & Care HIV and AIDS treatmentHIV and AIDS TreatmentHIV and AIDS Treatment & CareHIV Treatment for ChildrenStarting, monitoring & switching HIV treatmentHIV and AIDS care HIV and AIDS CareHIV and AIDS Home Based CareHIV/AIDS and PainPalliative CareHIV and AIDS drugsAntiretroviral Drug Side EffectsAntiretroviral Drugs TableHIV and AIDS DrugsNew Antiretroviral DrugsTreatment accessAIDS, Drug Prices and Generic DrugsTreatment AccessUniversal Access to HIV/AIDS TreatmentAIDS-related infectionsHIV Opportunistic Infections: Prevention and TreatmentHIV/AIDS & related InfectionsStages of HIV InfectionTuberculosisOther treatment and careAlternative and Traditional Medicine for HIVHIV and NutritionHIV & AIDS Around The World AfricaThe HIV & AIDS epidemic in AfricaGay Men in Africa and HIV/AIDSHIV and AIDS in AfricaHIV and AIDS in Africa QuestionsThe Impact of HIV & AIDS in AfricaAfrican countriesHIV & AIDS in BotswanaHIV & AIDS in MalawiHIV and AIDS in KenyaHIV and AIDS in NigeriaHIV and AIDS in South AfricaHIV and AIDS in SwazilandHIV and AIDS in TanzaniaHIV and AIDS in UgandaHIV and AIDS in ZambiaHIV and AIDS in ZimbabweHIV and AIDS in LesothoHistory of HIV & AIDS in AfricaHistory of HIV & AIDS in AfricaHistory of HIV & AIDS in South AfricaTimeline of AIDS in AfricaAmericasHIV & AIDS in the United StatesHistory of HIV & AIDS in the United States of AmericaHIV & AIDS in the United States of AmericaHIV & AIDS Treatment in the United States of AmericaHIV and AIDS Among African AmericansHelp and advice for HIV and AIDS in AmericaUSA HIV & AIDS Help and AdviceHIV & AIDS in Latin America and the CaribbeanHIV & AIDS in BrazilHIV and AIDS in Latin AmericaHIV and AIDS in the CaribbeanAsia & EuropeHIV & AIDS in AsiaHIV & AIDS in ChinaHIV & AIDS in ThailandHIV and AIDS in AsiaOverview of HIV and AIDS in IndiaTimeline of AIDS in AsiaWho is Affected by HIV and AIDS in India?HIV & AIDS in EuropeHistory of HIV & AIDS in the UK 1981-1995History of HIV & AIDS in the UK 1996 OnwardsHIV and AIDS in Russia, Eastern Europe & Central AsiaHIV and AIDS in the UKHIV and AIDS in Western and Central EuropeHIV and AIDS Treatment in the UKHelp and advice in the UKHelp and Advice for HIV/AIDS in the UKWho Has to Pay for NHS Treatment in the UK?Sex, Sexuality & Relationships STDsGay & LesbianGay & LesbianAm I Gay? Are You Born Gay? Can You Stop Being Gay?Coming outGay and LesbianGay SexHomophobia, Prejudice & Attitudes to Gay Men & LesbiansHomosexual or Gay?How Many Gay People Are There?Lesbians, Bisexual Women and Safe SexYoung & GayBeing Gay at SchoolHIV, AIDS and Young Gay MenGay & LesbianAm I a Lesbian?Am I Gay?Young Gay Men & LesbiansResources & helpResources for people who are gay, lesbian or unsure'Young Gay Men Talking' booklet [PDF]STDsCommon STDsChlamydia Genital Warts HPVGonorrhea Hepatitis A, B & CHerpes STD PicturesSTIs or STDsSyphilisSTD StatisticsSTD Statistics WorldwideSTDs in AmericaSTDs in the UKSexInformation about sex Condoms & Spermicides questionsContraception questionsHow to Have SexOral SexPregnancy QuestionsSex QuestionsWorldwide Ages of ConsentYoung PeopleRelationships & SexAm I Ready for Sex?Being Gay, Sexuality and Attraction Having SexHaving Sex for the First TimeRelationships and FeelingsRelationships and Sex Your Body and PubertyPuberty and Boys' BodiesPuberty, Periods and Girls' BodiesYour Body, Puberty and Sexual Organs Having Safer SexAbout HIV/AIDS for Young PeopleAbout STIs & STDs for Young PeopleBirth Control and Contraception for Young PeopleCondom Tips for Young PeopleDrink, Drugs & SexHaving Safer SexSex, the Internet and TechnologySex, the Law and Young PeopleHIV-positive LifeBeing HIV-positive and HealthyFinding Out That You're HIV-positiveFriends, Attitudes and HIVSex and Relationships for HIV-positive Young PeopleFAQ about sexQuestions About Sex for Young PeopleOther WebsitesGo Ask Alice!Sex, Etc.BBC - The SurgeryPhotos, Videos, Games & Stories Games Play our games to test your knowledge and skills, while learning new facts. See how much you know about HIV/AIDS and sexual health, with our AIDS Game, Sex Education Game, Pregnancy Game and Condom Game. Use your mouse to collect the right letters while avoiding the baddies for a chance to appear on our HI-scores table. Give our games a try now, and see how well you can do! AIDS Game Pregnancy Game Sex Education Game Condom Game Photos & Videos Our media gallery contains hundreds of HIV and AIDS related photos, videos and graphics. You can have a look around, use the search feature, or take a look at some photo selections. Photo Selections Photos & Videos Gallery Media Types Photos Graphics Videos Search the Media Gallery Latest media: Quizzes Try our quizzes to test your knowledge on all aspects of sexual health and HIV and AIDS. We have a Sex Quiz, Pregnancy Quiz, Condom Quiz and an HIV and AIDS Quiz. Just a beginner? Then try the quizzes' easy levels. Think you're an expert? Well try the hard quizzes. AIDS Challenge HIV and AIDS Quiz Pregnancy Quiz Sex Education Quiz Condom Quiz StoriesLesbian and gay storiesComing out StoriesYoung Bisexual and Gay Men: Personal StoriesYoung Lesbian and Bisexual: Personal StoriesHIV and AIDSHIV and AIDS in the FamilyPersonal Stories of Men Living with HIVPersonal Stories of Women Living with HIVPersonal Stories of Young People Living with HIVStories From Around the WorldTalking about sex First Time Sex StoriesStories of Sex EducationSubmit a storyFeatured Story I went through kind of a phase shift from just getting feelings towards this one guy, to be being confused and feeling kind of bi... - Submitted by Wesley Read more >> InternationalYouth Day 2013 Involving youth in the HIV response Giving young people a platform to share their thoughts and experiences raises awareness among their peers and gives an invaluable insight into the needs of this high-risk group. More than 2,400 young people are newly infected with HIV every day, accounting for 40% of new adult infections. Involving youth in the HIV response is key to lowering new HIV infections among the next generation and the role of technology in doing this is now clearer than ever. A sneak preview of results from an AVERT survey, due to be released on International Youth Day 2013 - 12 August, show that most young people prefer to get their sexual health and HIV/AIDS information online or via mobile, as it's quicker, confidential and cheap. But not all youth are the same, we've found regional variations in the type of technology young people prefer - with 67% of respondents from Africa using mobile phones for health information, compared to just 31% in Europe. To commemorate International Youth Day 2013 - 12 August, share your experiences with others by sending AVERT your story. Raise HIV awareness among youth, check out the hints, tips and quizzes below and share them with your friends. Young People Zone Quizzes 'Can't Explain' home pageTemas sobre el VIH y el SIDA ¿Puede Contraer SIDA De. . . ?Síntomas Del VIH Y Del SIDASIDAVIHPruebas De Detección Del VIHVIH, Embarazo, Madres Y BebésVisión General De La Prevención De VIHIntroducción Al Tratamiento De VIH Y SIDALa Evidencia De Que El VIH Causa El SIDALas Estadísticas Del SIDA Y VIH En El MundoSexo, sexualidad y las relaciones ¿Cómo Se Tiene Sexo?Preguntas Generales Sobre SexoUso De Condones, Tipos Y Tamaños De Condones¿Soy Gay? ¿Se Nace Gay? ¿Se Puede Dejar De Ser Gay?Enfermedades De Transmisión Sexual Y Síntomas De ETSMedia, juegos y concursos Fotos y VideosJuegos (en Inglés) Search Avert.org Click to search site search back to content
'Hepatitis' refers to viral infections that cause inflammation of the liver. Hepatitis A, B and C are the most common types. Each have different causes and symptoms.
Hepatitis A is the most common of the seven known types of viral hepatitis. Infection with the hepatitis A virus leads to inflammation of the liver, but complications are rarely serious.
The hepatitis A virus (HAV) is found in the faeces of someone infected with the virus. It only takes a tiny amount of faeces getting inside another person’s mouth to cause hepatitis A infection. Personal hygiene, such as careful hand washing, can minimise the risk of the virus being passed on.
HAV is a common infection in many parts of the world where sanitation and sewage infrastructure is poor. Often people become infected with HAV by eating or drinking contaminated food or water.
Hepatitis A is also classed as a sexually transmitted disease (STD) because it can be passed on sexually, particularly during activities such as anilingus (rimming). The washing of genital and anal areas before sex, and the use of condoms or dental dams can help to prevent this risk.
Hepatitis A can affect all age groups. Once a person is exposed to the virus it takes between 2 and 6 weeks to produce symptoms.
It is possible to experience mild or no symptoms whatsoever, but even if this is the case the person’s faeces will still be infectious to others. Many people who become infected with HAV will have symptoms that include:
The infection usually clears in up to 2 months, but may occasionally recur or persist longer in some people. Once a person has been infected and their body has fought off the virus they are permanently immune. Occasionally symptoms may be severe and require monitoring in hospital.
There are rarely any complications with hepatitis A infection. Permanent damage to the liver is very unlikely, but in extremely rare cases the infection can be fatal, particularly in older people.
If you have any symptoms or you are worried you may have been infected with hepatitis A, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can.
Some countries have specific sexual health clinics that can help you directly.
HAV is tested for using a blood test. A positive test result means the patient has either had a past infection or is currently infected. The type of antibody detected in the test will indicate whether the infection is current or has been cleared. A patient who tests positive may be asked about recent contacts and sexual partners that may need to be tested too. A patient who has already had the infection and fought it off is naturally immune to HAV.
A negative test result means the patient is not infected with Hepatitis A. If the patient is believed to be at high or ongoing risk of infection, a doctor may advise immunisation.
There is no specific treatment for HAV and most people fight off the virus naturally, returning to full health within a couple of months. The doctor will advise avoiding alcohol and fatty foods as these can be hard for the liver to process and may exacerbate the inflammation.
Patients should get plenty of rest and eat a nutritious diet. They should also ensure they do not spread HAV by washing their hands after using the toilet and before preparing food. Patients with more severe symptoms may be monitored in hospital for a short period.
Hepatitis A immunisation is given in a series of injections. The first single injection in the arm gives protection for a year. The second booster injection at 6 to 12 months extends protection for up to 10 years.
The hepatitis A vaccine may be routinely recommended for young children living in areas with high incidence of hepatitis A, and anyone travelling to countries where hepatitis A is endemic. In addition, immunisation may be recommended for people whose sexual practices are likely to put them at risk.
Immunisation may also be recommended to prevent hepatitis A developing if a person suspects they have been exposed to the virus.
Someone who is infected with hepatitis A should limit the amount of alcohol they drink. Their doctor may also offer dietary advice.
The doctor will advise about any precautions necessary to avoid infecting others with the virus.
back to top
Hepatitis B is similar to hepatitis A in its symptoms, but is more likely to cause chronic long-term illness and permanent damage to the liver if not treated.
The hepatitis B virus (HBV) is very common worldwide, with more than 350 million people infected. Those with long term HBV are at high risk of developing liver cirrhosis or liver cancer.
Hepatitis B is most frequently passed on through the exchange of bodily fluids with an infected person. HBV is estimated to be 50 to 100 times more infectious than HIV.1
HBV can be spread in the following ways:
Hepatitis B cannot be spread through sneezing, coughing, hugging or coming in contact with the faeces of someone who is infected.
Many people who become infected with HBV experience mild symptoms or no symptoms at all, but they may still carry the infectious virus and pass it on to others. When symptoms do appear they are similar to those of hepatitis A and may include:
If symptoms become severe then a person with hepatitis B may be admitted to hospital.
Most adults infected with the hepatitis B virus fully recover and develop life-long immunity. Between 2% and 10% of individuals infected as adults will become chronic carriers, which means they will be infectious to others and can develop chronic liver damage. Infected children, especially newborn babies, are much more likely to become chronic carriers.
If a person lives with hepatitis B infection for a number of years then they may develop the following complications:
If you have any symptoms or you are worried you may have been infected with hepatitis B, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can.
A positive test result could indicate either of the following:
A doctor may perform a number of different types of test to distinguish between current and past infections, and to estimate how infectious a patient with a current infection may be.
This result generally means the patient has never been infected with HBV and therefore has no natural immunity against the virus. If the person suspects they may have been recently exposed to HBV, the doctor may advise them to take a repeat test to confirm their negative status, and may also advise immunisation against hepatitis B.
In most countries a patient with a positive test result will be referred to a specialist who will carry out further tests to determine the degree to which hepatitis B may be affecting the liver, and what may be the best treatment options. In these tests a small sample of liver tissue may need to be taken (a liver biopsy).
In the majority of patients with active HBV, symptoms will not be severe and treatment will not be required. The patient will be monitored and after a few months the patient’s immune system should fight off the virus, giving the patient natural immunity.
In around 5% of adults, 30-50% of young children (aged 1-4), and 90% of infants, HBV infection will become chronic. The virus is more deadly to the young and those that are infected at birth have a 25% chance of developing a life-threatening liver-related illness.
Antiviral medication is given as treatment to those with chronic symptoms to help prevent further liver damage. These medications may be injected or given in pill form. Examples are Interferon Alpha, Lamivudine and Baraclude. Treatment usually lasts 6 months, during which time the patient will be carefully monitored.
Regardless of whether the infection is producing symptoms or not, the patient will be advised to avoid alcohol, get plenty of rest and maintain a healthy diet.
Three immunisation injections are given over a period of 3-6 months. A blood test is taken once the course of injections is completed to check they have worked. Immunity should last for at least 5 years.
A patient with an active infection will be advised to have regular blood tests and physical check-ups to monitor the virus, even if they are not receiving treatment. All carriers of HBV should expect to be referred to specialist services.
The doctor or nurse may advise the patient to avoid alcohol, fatty foods and follow a low-salt diet. They will also describe any precautions necessary to ensure the patient avoids infecting others with the virus, such as not sharing toothbrushes or shaving equipment.
It is important to use a condom for penetrative sex to prevent passing on the virus. Sexual partners of the patient should be tested and immunised against HBV (if not already infected).
Hepatitis C, like other forms of hepatitis, causes inflammation of the liver. The hepatitis C virus is transferred primarily through blood, and is more persistent than hepatitis A or B.2
The hepatitis C virus (HCV) can be spread in the following ways:
Hepatitis C cannot be passed on by hugging, sneezing, coughing, sharing food or water, sharing cutlery, or casual contact.
Many people do not have symptoms when they become infected with hepatitis C. Symptoms may emerge later, taking anywhere between 15 and 150 days to develop. Occasionally a person will not develop any symptoms and their immune system will successfully clear the virus without their knowledge. An infected person without symptoms can still act as a carrier and pass the virus on to others.
Symptoms may include:
About 20% of individuals who become infected with HCV will clear the virus from their body within 6 months, though this does not mean they are immune from future infection with HCV.
The other 80% of people will develop chronic hepatitis C infection, during which the virus may cause mild symptoms or no symptoms at all. These people will however carry the hepatitis C virus for the rest of their lives and will remain infectious to others.
If a person lives with hepatitis C infection for a number of years then they may develop the following complications:
If symptoms become severe then a person with hepatitis C may be admitted to hospital for monitoring and treatment.
If you have any symptoms or you are worried you may have been infected with hepatitis C, you should discuss your worries with a doctor. They may be able to run tests themselves, or else will refer you to someone who can.
Tests for the hepatitis C virus have only been available since 1989. A doctor can diagnose hepatitis C by carrying out blood tests that detect HCV antibodies in the blood.
The first test searches for HCV antibodies in the patient’s blood. A positive result shows that the person has been exposed to the hepatitis C virus and their immune system has responded by producing antibodies.
This may mean that the patient is a carrier of the hepatitis C virus. Alternatively, the patient may have recently cleared an HCV infection and still have antibodies in their blood. Further tests will be conducted to find out whether the patient has a current infection.
A specialist will carry out a blood test that looks for the genetic material of the hepatitis C virus itself instead of the antibodies. This test will identify whether the virus is still present.
If the patient has successfully cleared the virus, this does not mean they are immune to reinfection.
A negative result generally means the patient has never been infected with HCV. However, as the tests rely on the detection of antibodies to HCV, and the antibodies can take some months to develop, the doctor may advise the patient to take a repeat test if they believe they may have been recently exposed to the virus.
To determine the extent to which the liver has been affected by hepatitis C, other tests may be carried out. These include liver function tests, which measure substances (specific proteins and enzymes) in the patient’s blood, showing how effectively the liver is working. A liver biopsy may also be carried out. A fine hollow needle is passed through the skin into the liver and a small sample is taken. The sample is then examined under a microscope to gauge the amount of liver damage (inflammation, scarring and cirrhosis).
Treatment combines the antiviral drugs interferon and ribavirin. Although treatment has improved in recent years, the success rates vary depending on which genotype the patient has and how long they have had hepatitis C. In 2011, the FDA approved a new drug called Victrelis (for the treatment of the genotype 1 strain of hepatitis C). When taken alongside existing drugs, Victrelis cured more than 60 percent of patients in clinical trials compared to between 20-40 percent of patients when existing drugs were taken alone.3 Unlike other drugs for hepatitis C, Victrelis is a protease inhibitor, similar to those used to treat HIV. Adherence to this drug is essential to prevent drug resistance.
The antiviral drugs may cause significant side effects that may be intolerable for some people. These include:
A patient will also require regular check-ups to monitor their progress. It is important to remember that if HCV treatment is effective and the infection is cleared, this does not mean the patient has future immunity to hepatitis C.
If a patient has been diagnosed with hepatitis C infection, they will be advised to have regular blood tests and physical check-ups.
The infected person should limit the amount of alcohol they drink as alcohol puts strain on the liver. The doctor may also advise avoiding fatty foods and following a low-salt diet.
Currently, there is no vaccine for hepatitis C, but research is in progress. Like HIV, HCV can mutate easily, which makes vaccine development complicated. As no vaccine exists, all measures should be taken to prevent HCV transmission.
Injecting drug users should never share any needles, syringes or mixing spoons, as blood can be transferred between users.
Infection through penetrative sex does occur, although it is not common. If a person is infected with HCV, it is advisable for them to use a condom for penetrative sex to ensure they do not pass on the virus to their partners through any open genital cuts or sores.
People should avoid sharing toothbrushes, shaving equipment (especially razors), or anything else that may be contaminated with infected blood.
The doctor will advise the patient of any precautions necessary to avoid infecting others with the virus.
english español
Play our games to test your knowledge and skills, while learning new facts. See how much you know about HIV/AIDS and sexual health, with our AIDS Game, Sex Education Game, Pregnancy Game and Condom Game. Use your mouse to collect the right letters while avoiding the baddies for a chance to appear on our HI-scores table.
Give our games a try now, and see how well you can do!
Our media gallery contains hundreds of HIV and AIDS related photos, videos and graphics. You can have a look around, use the search feature, or take a look at some photo selections.
Try our quizzes to test your knowledge on all aspects of sexual health and HIV and AIDS. We have a Sex Quiz, Pregnancy Quiz, Condom Quiz and an HIV and AIDS Quiz.
Just a beginner? Then try the quizzes' easy levels. Think you're an expert? Well try the hard quizzes.
I went through kind of a phase shift from just getting feelings towards this one guy, to be being confused and feeling kind of bi... - Submitted by Wesley Read more >>
Giving young people a platform to share their thoughts and experiences raises awareness among their peers and gives an invaluable insight into the needs of this high-risk group. More than 2,400 young people are newly infected with HIV every day, accounting for 40% of new adult infections.
Involving youth in the HIV response is key to lowering new HIV infections among the next generation and the role of technology in doing this is now clearer than ever.
A sneak preview of results from an AVERT survey, due to be released on International Youth Day 2013 - 12 August, show that most young people prefer to get their sexual health and HIV/AIDS information online or via mobile, as it's quicker, confidential and cheap. But not all youth are the same, we've found regional variations in the type of technology young people prefer - with 67% of respondents from Africa using mobile phones for health information, compared to just 31% in Europe.
To commemorate International Youth Day 2013 - 12 August, share your experiences with others by sending AVERT your story. Raise HIV awareness among youth, check out the hints, tips and quizzes below and share them with your friends.